Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Long-term use of salmeterol for exercise-induced asthma results in decreased duration of action

July 22, 1998

FR-167653 attenuates ischemia-reperfusion injury to the lung in rat model

July 20, 1998

PathoGenesis completes patient enrollment in phase II TOBI trial

July 20, 1998

Singulair introduced in Germany for asthma

July 17, 1998

Yamanouchi identifies NK1 antagonist with good antiasthmatic activity

July 17, 1998

Zyrtec registered in Japan, launch scheduled for September

July 14, 1998

Investigation at Kowa results in development of potent CysLT1 receptor antagonists

July 7, 1998

U.S. patent issues for second product in PathoGenesis' pipeline

July 7, 1998

Bio-Technology General's OxSODrol study being continued with revised endpoints

July 6, 1998

Approvable letter issued for Xopenex

July 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026